Delivery Order SPE2DB20D2002-SPE2DB24FL64A

Award Date 6/27/24
Potential Completion Date 7/19/24
Potential Value $94K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The award is a delivery order with a firm fixed price of $9,559.70 and an ultimate completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Department of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,811.03 and a completion date of July 17, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccines with diluents to the U.S. government. The contract, which has a ceiling value of $1,911.94, was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of August 5, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The $22,488.24 firm fixed-price delivery order has a completion date of July 22, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant $999,999,999.00 Indefinite Delivery Contract with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract, valued at $5,622.06, has a completion date of June 4, 2024 and was awarded on May 13, 2024. Amerisourcebergen has a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA) for a total ceiling value of $4,685.05. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $5,735.82, is for the delivery of VARIVAX vaccine with diluents. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the VARIVAX vaccine with diluents to the Defense Logistics Agency (DLA). The contract has a ceiling value of $7,647.84 and an ultimate completion date of May 22, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $93,701.00 firm fixed-price delivery order is for the supply of the VARIVAX vaccine with diluents. The contract has an ultimate completion date of June 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, the...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,513.93 firm fixed-price delivery order is for the supply of VARIVAX vaccines with diluents, with an ultimate completion date of October 22, 2024. The contract is not set aside for any specific business category. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous Indefinite...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB24FL64A
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VARIVAX vaccines with diluents to the Defense Logistics Agency (DLA). The contract, valued at $93,701.00, is a Firm Fixed Price Delivery Order with a completion date of July 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is not designated as a set-aside contract.

Generated 9/26/24, 9:20 AM